{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:31:39Z","timestamp":1786480299724,"version":"build-2736575974"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) to extremely preterm infants reduces the risk of severe retinopathy of prematurity (ROP). The main aim of this study was to explore the involvement of AA:DHA supplementation in the developing gut microbiome, and its possible contribution to the ROP-protective effect. Secondly, additional covariates for microbiome maturation were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Longitudinal gut microbiome profiles and bacterial gene pathways were characterised using shot-gun metagenomics in 75 extremely preterm infants who participated in a randomized clinical trial on AA:DHA supplementation. Serum protein levels quantified using proximity extension assays were merged with the microbiome data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AA:DHA supplementation was linked to an increase in relative abundance of\n                      <jats:italic>Citrobacter koseri<\/jats:italic>\n                      and associated with changes in proteins and metabolic pathways. Occurrence of severe ROP was associated with microbiome alpha diversity (Shannon and Evenness) and beta diversity (Bray-Curtis). Additionally, study centre and gestational age at birth impacted the microbiome composition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We conclude that AA:DHA supplementation impacts the microbiome. However, the current study could not determine the causality between the supplementation, microbiome and ROP-decrease. Nonetheless, these findings highlight the complex interplay between external interventions, including nutritional supplements, and the gut microbiome development in extremely preterm infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Longitudinal gut microbiome profiles, bacterial gene pathways and serum protein expressions were determined using shotgun metagenomics and proximity extension assays in 75 extremely preterm infants included in a multicentre randomized clinical trial investigating enteral fatty acid supplementation.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Dynamic shifts in microbiome and pathway composition were seen from birth to 34 weeks gestational age.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Arachidonic acid (AA) and docosahexaenoic acid (DHA) supplementation was linked to an increase in relative abundance of\n                            <jats:italic>Citrobacter koseri<\/jats:italic>\n                            and associated with changes in proteins and metabolic pathways. However, the causality between the supplementation, microbiome, and ROP-decrease could not be determined.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-026-05290-z","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T20:18:31Z","timestamp":1784146711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Supplementation with long-chain polyunsaturated fatty acids to extremely preterm infants associates with development of the intestinal microbiota"],"prefix":"10.1038","author":[{"given":"Hanna","family":"Danielsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Portlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"S\u00e4vman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Wackernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hansen-Pupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Shoaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Uhl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Brusselaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1912-9563","authenticated-orcid":false,"given":"Anders","family":"Elfvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"5290_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jamapediatrics.2020.5653","volume":"175","author":"A Hellstr\u00f6m","year":"2021","unstructured":"Hellstr\u00f6m, A. et al. Effect of enteral lipid supplement on severe retinopathy of prematurity: a randomized clinical trial. JAMA Pediatr. 175, 359\u2013367 (2021).","journal-title":"JAMA Pediatr."},{"key":"5290_CR2","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.clnu.2024.03.031","volume":"43","author":"S Klevebro","year":"2024","unstructured":"Klevebro, S. et al. Arachidonic acid and docosahexaenoic acid levels correlate with the inflammation proteome in extremely preterm infants. Clin. Nutr. 43, 1162\u20131170 (2024).","journal-title":"Clin. Nutr."},{"key":"5290_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41390-024-03775-3","volume":"98","author":"P Lundgren","year":"2025","unstructured":"Lundgren, P. et al. Platelet characteristics in extremely preterm infants after fatty acid supplementation: a randomized controlled trial. Pediatr. Res. 98, 680\u2013689 (2025).","journal-title":"Pediatr. Res."},{"key":"5290_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112918","volume":"28","author":"Z Tan","year":"2025","unstructured":"Tan, Z. et al. Immune development differs between preterm newborns fed mothers\u2019 own milk and donor milk. iScience 28, 112918 (2025).","journal-title":"iScience"},{"key":"5290_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/jamaophthalmol.2025.5594","volume":"144","author":"P Lundgren","year":"2026","unstructured":"Lundgren, P. et al. Proteomic profile in retinopathy of prematurity: a secondary analysis of the mega donna mega randomized clinical trial. JAMA Ophthalmol. 144, 174\u2013184 (2026).","journal-title":"JAMA Ophthalmol."},{"key":"5290_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaophthalmol.2025.5994","volume":"144","author":"P Lundgren","year":"2026","unstructured":"Lundgren, P. et al. Fatty acid supplementation and retinopathy of prematurity: secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 144, 279\u2013281 (2026).","journal-title":"JAMA Ophthalmol."},{"key":"5290_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2026.101030","volume":"67","author":"AK Nilsson","year":"2026","unstructured":"Nilsson, A. K. et al. Low serum sphingosine-1-phospate and its chaperone ApoM associate with retinopathy of prematurity. J. Lipid Res. 67, 101030 (2026).","journal-title":"J. Lipid Res"},{"key":"5290_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.clnu.2023.04.020","volume":"42","author":"U Sj\u00f6bom","year":"2023","unstructured":"Sj\u00f6bom, U. et al. Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid\/arachidonic acid: A secondary analysis of the Mega Donna Mega trial. Clin. Nutr. 42, 962\u2013971 (2023).","journal-title":"Clin. Nutr."},{"key":"5290_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/s12887-024-05203-1","volume":"24","author":"V Golubinskaya","year":"2024","unstructured":"Golubinskaya, V. et al. Cytokine and growth factor correlation networks associated with morbidities in extremely preterm infants. BMC Pediatr. 24, 723 (2024).","journal-title":"BMC Pediatr."},{"key":"5290_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8879227","volume":"2021","author":"Y Fu","year":"2021","unstructured":"Fu, Y. et al. Associations among Dietary Omega-3 Polyunsaturated Fatty Acids, the Gut Microbiota, and Intestinal Immunity. Mediators Inflamm. 2021, 8879227 (2021).","journal-title":"Mediators Inflamm."},{"key":"5290_CR11","doi-asserted-by":"publisher","unstructured":"Shetty, S., Luca, R., Rodriguez, S. H. & Skondra, D. A potential gut-retina axis in retinopathy of prematurity: emerging perspectives on microbiome-mediated modulation of the IGF-1-VEGF pathway. Int. J. Mol. Sci. 27, https:\/\/doi.org\/10.3390\/ijms27073317 (2026).","DOI":"10.3390\/ijms27073317"},{"key":"5290_CR12","doi-asserted-by":"publisher","unstructured":"De Cillis, F. et al. Restoring balance: the role of omega-3 polyunsaturated fatty acids on the gut-brain axis and other interconnected biological pathways to improve depression. Nutrients 17, https:\/\/doi.org\/10.3390\/nu17213426 (2025).","DOI":"10.3390\/nu17213426"},{"key":"5290_CR13","doi-asserted-by":"publisher","unstructured":"Zhang, J. Y., Greenwald, M. J. & Rodriguez, S. H. Gut microbiome and retinopathy of prematurity. Am. J. Pathol. https:\/\/doi.org\/10.1016\/j.ajpath.2023.01.013 (2023).","DOI":"10.1016\/j.ajpath.2023.01.013"},{"key":"5290_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaapos.2020.03.010","volume":"24","author":"D Skondra","year":"2020","unstructured":"Skondra, D. et al. The early gut microbiome could protect against severe retinopathy of prematurity. J. Aapos 24, 236\u2013238 (2020).","journal-title":"J. Aapos"},{"key":"5290_CR15","doi-asserted-by":"publisher","unstructured":"Schiavone, N. et al. Exploring the gut microbiota-retina axis: implications for health and disease. Microorganisms 13, https:\/\/doi.org\/10.3390\/microorganisms13051101 (2025).","DOI":"10.3390\/microorganisms13051101"},{"key":"5290_CR16","doi-asserted-by":"publisher","first-page":"307ra152","DOI":"10.1126\/scitranslmed.aab2271","volume":"7","author":"MC Arrieta","year":"2015","unstructured":"Arrieta, M. C. et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 7, 307ra152 (2015).","journal-title":"Sci. Transl. Med."},{"key":"5290_CR17","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1136\/gutjnl-2018-317503","volume":"68","author":"MG Dominguez-Bello","year":"2019","unstructured":"Dominguez-Bello, M. G., Godoy-Vitorino, F., Knight, R. & Blaser, M. J. Role of the microbiome in human development. Gut 68, 1108\u20131114 (2019).","journal-title":"Gut"},{"key":"5290_CR18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm.4176","volume":"22","author":"KE Fujimura","year":"2016","unstructured":"Fujimura, K. E. et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat. Med. 22, 1187\u20131191 (2016).","journal-title":"Nat. Med."},{"key":"5290_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.trsl.2016.06.010","volume":"179","author":"CC Johnson","year":"2017","unstructured":"Johnson, C. C. & Ownby, D. R. The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases. Transl. Res. 179, 60\u201370 (2017).","journal-title":"Transl. Res"},{"key":"5290_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2020.08.065","volume":"160","author":"V Ronan","year":"2021","unstructured":"Ronan, V., Yeasin, R. & Claud, E. C. Childhood development and the microbiome-the intestinal microbiota in maintenance of health and development of disease during childhood development. Gastroenterology 160, 495\u2013506 (2021).","journal-title":"Gastroenterology"},{"key":"5290_CR21","doi-asserted-by":"publisher","first-page":"e2018119","DOI":"10.1001\/jamanetworkopen.2020.18119","volume":"3","author":"JC Roz\u00e9","year":"2020","unstructured":"Roz\u00e9, J. C. et al. Assessment of neonatal intensive care unit practices and preterm newborn gut microbiota and 2-year neurodevelopmental outcomes. JAMA Netw. Open 3, e2018119 (2020).","journal-title":"JAMA Netw. Open"},{"key":"5290_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02573-2","volume":"9","author":"J Stokholm","year":"2018","unstructured":"Stokholm, J. et al. Maturation of the gut microbiome and risk of asthma in childhood. Nat. Commun. 9, 141 (2018).","journal-title":"Nat. Commun."},{"key":"5290_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.clp.2017.01.005","volume":"44","author":"MA Underwood","year":"2017","unstructured":"Underwood, M. A. & Sohn, K. The microbiota of the extremely preterm infant. Clin. Perinatol. 44, 407\u2013427 (2017).","journal-title":"Clin. Perinatol."},{"key":"5290_CR24","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41590-019-0451-9","volume":"20","author":"TP Wypych","year":"2019","unstructured":"Wypych, T. P., Wickramasinghe, L. C. & Marsland, B. J. The influence of the microbiome on respiratory health. Nat. Immunol. 20, 1279\u20131290 (2019).","journal-title":"Nat. Immunol."},{"key":"5290_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104613","volume":"92","author":"A Bargheet","year":"2023","unstructured":"Bargheet, A. et al. Development of early life gut resistome and mobilome across gestational ages and microbiota-modifying treatments. EBioMedicine 92, 104613 (2023).","journal-title":"EBioMedicine"},{"key":"5290_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41390-018-0022-z","volume":"84","author":"DA Chernikova","year":"2018","unstructured":"Chernikova, D. A. et al. The premature infant gut microbiome during the first 6 weeks of life differs based on gestational maturity at birth. Pediatr. Res. 84, 71\u201379 (2018).","journal-title":"Pediatr. Res."},{"key":"5290_CR27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/dev.21826","volume":"61","author":"AL D\u2019Agata","year":"2019","unstructured":"D\u2019Agata, A. L. et al. Effects of early life NICU stress on the developing gut microbiome. Dev. Psychobiol. 61, 650\u2013660 (2019).","journal-title":"Dev. Psychobiol."},{"key":"5290_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/JPN.0000000000000506","volume":"34","author":"K Desorcy-Scherer","year":"2020","unstructured":"Desorcy-Scherer, K., Bendixen, M. M. & Parker, L. A. Determinants of the very low-birth-weight infant\u2019s intestinal microbiome: a systematic review. J. Perinat. Neonatal Nurs. 34, 257\u2013275 (2020).","journal-title":"J. Perinat. Neonatal Nurs."},{"key":"5290_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/ANC.0000000000000220","volume":"15","author":"LE Hartz","year":"2015","unstructured":"Hartz, L. E., Bradshaw, W. & Brandon, D. H. Potential NICU environmental influences on the neonate\u2019s microbiome: a systematic review. Adv. Neonatal Care 15, 324\u2013335 (2015).","journal-title":"Adv. Neonatal Care"},{"key":"5290_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2020.08.047","volume":"183","author":"K Korpela","year":"2020","unstructured":"Korpela, K. et al. Maternal fecal microbiota transplantation in cesarean-born infants rapidly restores normal gut microbial development: a proof-of-concept study. Cell 183, 324\u2013334.e325 (2020).","journal-title":"Cell"},{"key":"5290_CR31","doi-asserted-by":"publisher","unstructured":"Morais, J. et al. Influence of human milk on very preterms\u2019 gut microbiota and alkaline phosphatase activity. Nutrients 13, https:\/\/doi.org\/10.3390\/nu13051564 (2021).","DOI":"10.3390\/nu13051564"},{"key":"5290_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41586-021-03241-8","volume":"591","author":"C Rao","year":"2021","unstructured":"Rao, C. et al. Multi-kingdom ecological drivers of microbiota assembly in preterm infants. Nature 591, 633\u2013638 (2021).","journal-title":"Nature"},{"key":"5290_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28525-z","volume":"13","author":"M Reyman","year":"2022","unstructured":"Reyman, M. et al. Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial. Nat. Commun. 13, 893 (2022).","journal-title":"Nat. Commun."},{"key":"5290_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00163-22","volume":"7","author":"D Seki","year":"2022","unstructured":"Seki, D. et al. Individuality of the extremely premature infant gut microbiota is driven by ecological drift. mSystems 7, e0016322 (2022).","journal-title":"mSystems"},{"key":"5290_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44547-y","volume":"9","author":"NE Younge","year":"2019","unstructured":"Younge, N. E. et al. Disrupted maturation of the microbiota and metabolome among extremely preterm infants with postnatal growth failure. Sci. Rep. 9, 8167 (2019).","journal-title":"Sci. Rep."},{"key":"5290_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0214-x","volume":"4","author":"KE Gregory","year":"2016","unstructured":"Gregory, K. E. et al. Influence of maternal breast milk ingestion on acquisition of the intestinal microbiome in preterm infants. Microbiome 4, 68 (2016).","journal-title":"Microbiome"},{"key":"5290_CR37","first-page":"2571","volume":"38","author":"TSNUH Tabuchi","year":"1974","unstructured":"Tabuchi, T. S. N. U. H. A novel pathway for the partial oxidation of propionyl-CoA to pyruvate via seven carbon tricarboxylic acids in yeasts. Agric. Biol. Chem. 38, 2571\u20132572 (1974).","journal-title":"Agric. Biol. Chem."},{"key":"5290_CR38","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.chom.2015.04.004","volume":"17","author":"F B\u00e4ckhed","year":"2015","unstructured":"B\u00e4ckhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 690\u2013703 (2015).","journal-title":"Cell Host Microbe"},{"key":"5290_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/omi.2018.0013","volume":"22","author":"I Laudadio","year":"2018","unstructured":"Laudadio, I. et al. Quantitative assessment of shotgun metagenomics and 16S rDNA amplicon sequencing in the study of human gut microbiome. Omics 22, 248\u2013254 (2018).","journal-title":"Omics"},{"key":"5290_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.923273","volume":"13","author":"Q Jia","year":"2022","unstructured":"Jia, Q. et al. Dynamic changes of the gut microbiota in preterm infants with different gestational age. Front. Microbiol. 13, 923273 (2022).","journal-title":"Front. Microbiol."},{"key":"5290_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100206","volume":"2","author":"M Mart\u00ed","year":"2021","unstructured":"Mart\u00ed, M. et al. Effects of Lactobacillus reuteri supplementation on the gut microbiota in extremely preterm infants in a randomized placebo-controlled trial. Cell Rep. Med. 2, 100206 (2021).","journal-title":"Cell Rep. Med"},{"key":"5290_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41390-021-01831-w","volume":"92","author":"AA Salas","year":"2022","unstructured":"Salas, A. A. et al. The gut microbiome of extremely preterm infants randomized to the early progression of enteral feeding. Pediatr. Res. 92, 799\u2013804 (2022).","journal-title":"Pediatr. Res."},{"key":"5290_CR43","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.chom.2022.04.005","volume":"30","author":"J Samara","year":"2022","unstructured":"Samara, J. et al. Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host Microbe 30, 696\u2013711.e695 (2022).","journal-title":"Cell Host Microbe"},{"key":"5290_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MPG.0000000000002549","volume":"70","author":"GR Young","year":"2020","unstructured":"Young, G. R. et al. Acquisition and development of the extremely preterm infant microbiota across multiple anatomical sites. J. Pediatr. Gastroenterol. Nutr. 70, 12\u201319 (2020).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"5290_CR45","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41390-024-03208-1","volume":"96","author":"A Hellstr\u00f6m","year":"2024","unstructured":"Hellstr\u00f6m, A. et al. Nutritional interventions to prevent retinopathy of prematurity. Pediatr. Res. 96, 905\u2013911 (2024).","journal-title":"Pediatr. Res."},{"key":"5290_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.517207","volume":"8","author":"S Horsch","year":"2020","unstructured":"Horsch, S. et al. Randomized control trial of postnatal rhIGF-1\/rhIGFBP-3 replacement in preterm infants: post-hoc analysis of its effect on brain injury. Front Pediatr. 8, 517207 (2020).","journal-title":"Front Pediatr."},{"key":"5290_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100696","volume":"32","author":"P Lundgren","year":"2023","unstructured":"Lundgren, P. et al. Visual outcome at 2.5 years of age in \u03c9-3 and \u03c9-6 long-chain polyunsaturated fatty acid supplemented preterm infants: a follow-up of a randomized controlled trial. Lancet Reg. Health Eur. 32, 100696 (2023).","journal-title":"Lancet Reg. Health Eur."},{"key":"5290_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/0976-500X.72352","volume":"1","author":"KF Schulz","year":"2010","unstructured":"Schulz, K. F., Altman, D. G. & Moher, D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J. Pharm. Pharmacother. 1, 100\u2013107 (2010).","journal-title":"J. Pharm. Pharmacother."},{"key":"5290_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2431-13-59","volume":"13","author":"TR Fenton","year":"2013","unstructured":"Fenton, T. R. & Kim, J. H. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 13, 59 (2013).","journal-title":"BMC Pediatr."},{"key":"5290_CR50","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0031-3955(16)34975-6","volume":"33","author":"MC Walsh","year":"1986","unstructured":"Walsh, M. C. & Kliegman, R. M. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr. Clin. North Am. 33, 179\u2013201 (1986).","journal-title":"Pediatr. Clin. North Am."},{"key":"5290_CR51","unstructured":"Boulund, F., D J., Olsson, L. ctmrbio\/stag-mwc: StaG v0.4.1 (Version v0.4.1). Zenodo. 2021, 2021)."},{"key":"5290_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-022-00518-9","volume":"14","author":"N Brusselaers","year":"2022","unstructured":"Brusselaers, N., Pereira, M., Alm, J., Engstrand, L. & Engstrand Lilja, H. Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome: a pilot cohort. Gut Pathog. 14, 47 (2022).","journal-title":"Gut Pathog."},{"key":"5290_CR53","doi-asserted-by":"publisher","unstructured":"Hugerth, L. et al. A comprehensive automated pipeline for human microbiome sampling, 16S rRNA gene sequencing and bioinformatics processing. bioRxiv, 286526 https:\/\/doi.org\/10.1101\/286526 (2018).","DOI":"10.1101\/286526"},{"key":"5290_CR54","doi-asserted-by":"publisher","unstructured":"Hugerth, L. W. et al. Assessment of in vitro and in silico protocols for sequence-based characterization of the human vaginal microbiome. mSphere 5, https:\/\/doi.org\/10.1128\/mSphere.00448-20 (2020).","DOI":"10.1128\/mSphere.00448-20"},{"key":"5290_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s43856-023-00338-1","volume":"3","author":"W Zhong","year":"2023","unstructured":"Zhong, W. et al. The development of blood protein profiles in extremely preterm infants follows a stereotypic evolution pattern. Commun. Med. 3, 107 (2023).","journal-title":"Commun. Med."},{"key":"5290_CR56","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"5290_CR57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-1560-1","volume":"574","author":"Y Shao","year":"2019","unstructured":"Shao, Y. et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature 574, 117\u2013121 (2019).","journal-title":"Nature"},{"key":"5290_CR58","unstructured":"KEGG BRITE Database. Functional hierarchies of biological entities [Internet]. [Cited 2026 April 20]. Available from: https:\/\/www.genome.jp\/kegg\/brite.html."},{"key":"5290_CR59","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013d592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"5290_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"5290_CR61","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"5290_CR62","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1586\/14787210.2014.944505","volume":"12","author":"A Deveci","year":"2014","unstructured":"Deveci, A. & Coban, A. Y. Optimum management of Citrobacter koseri infection. Expert Rev. Anti Infect. Ther. 12, 1137\u20131142 (2014).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"5290_CR63","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1086\/515106","volume":"28","author":"TI Doran","year":"1999","unstructured":"Doran, T. I. The role of Citrobacter in clinical disease of children: review. Clin. Infect. Dis. 28, 384\u2013394 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"5290_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07563-6","volume":"9","author":"S Knorr","year":"2018","unstructured":"Knorr, S. et al. Widespread bacterial lysine degradation proceeding via glutarate and L-2-hydroxyglutarate. Nat. Commun. 9, 5071 (2018).","journal-title":"Nat. Commun."},{"key":"#cr-split#-5290_CR65.1","unstructured":"MetaCyc Metabolic Pathway Database. MetaCyc Pathway: 2-methylcitrate cycle I [Internet]. [Updated 2026 Feb 26"},{"key":"#cr-split#-5290_CR65.2","unstructured":"Cited 2026 April 20]. Available from: https:\/\/metacyc.org\/pathway?orgid=META&id=PWY0-42."},{"key":"5290_CR66","doi-asserted-by":"publisher","DOI":"10.1093\/femsml\/uqaf009","volume":"6","author":"L Korn","year":"2025","unstructured":"Korn, L., Brock, M. & Schuster, S. Metabolic pathway analysis of the methylcitrate cycle in bacteria and fungi identifies methylcitrate synthase as an antiinfective drug target. Microlife 6, uqaf009 (2025).","journal-title":"Microlife"},{"key":"5290_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1446595","volume":"15","author":"F Piskol","year":"2024","unstructured":"Piskol, F. et al. Biochemical and structural elucidation of the L-carnitine degradation pathway of the human pathogen Acinetobacter baumannii. Front. Microbiol. 15, 1446595 (2024).","journal-title":"Front. Microbiol."},{"key":"5290_CR68","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3892\/etm.2011.245","volume":"2","author":"X Meng","year":"2011","unstructured":"Meng, X. et al. 1,5-Anhydro-D-fructose: a natural antibiotic that inhibits the growth of gram-positive bacteria and microbial biofilm formation to prevent nosocomial infection. Exp. Ther. Med. 2, 625\u2013628 (2011).","journal-title":"Exp. Ther. Med."},{"key":"5290_CR69","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1099\/mic.0.000080","volume":"161","author":"JA Meadows","year":"2015","unstructured":"Meadows, J. A. & Wargo, M. J. Carnitine in bacterial physiology and metabolism. Microbiology 161, 1161\u20131174 (2015).","journal-title":"Microbiology"},{"key":"5290_CR70","unstructured":"The Human Protein Atlas. TNFRSF11B [Internet]. Stockholm: The Human Protein Atlas; 2026 [updated 2026 Nov 11; cited 2026 April 20]. Available from: https:\/\/www.proteinatlas.org\/ENSG00000164761-TNFRSF11B."},{"key":"5290_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09941-6","volume":"24","author":"S Kazemi-Sufi","year":"2024","unstructured":"Kazemi-Sufi, S., Alipour, S., Rabieepour, M., Roshan-Milani, S. & Naderi, R. Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-\u0392 ligand (RANKL), osteoprotegerin (OPG) and RANKL\/OPG ratio in mild and severe COVID-19. BMC Infect. Dis. 24, 1047 (2024).","journal-title":"BMC Infect. Dis."},{"key":"5290_CR72","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1021\/acs.jproteome.3c00576","volume":"22","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. Plasma TNFRSF11B as a new predictive inflammatory marker of sepsis-ARDS with endothelial dysfunction. J. Proteome Res. 22, 3640\u20133651 (2023).","journal-title":"J. Proteome Res."},{"key":"5290_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13883-y","volume":"11","author":"S Kimura","year":"2020","unstructured":"Kimura, S. et al. Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity. Nat. Commun. 11, 234 (2020).","journal-title":"Nat. Commun."},{"key":"5290_CR74","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000444638","volume":"85","author":"AA Karatza","year":"2016","unstructured":"Karatza, A. A., Fouzas, S., Giannakopoulos, I., Kritikou, D. & Chrysis, D. Influence of antenatal glucocorticosteroid exposure on osteoprotegerin and receptor activator of nuclear factor x03BA;B ligand levels in newborn infants. Horm. Res. Paediatr. 85, 257\u2013264 (2016).","journal-title":"Horm. Res. Paediatr."},{"key":"5290_CR75","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1038\/s41433-025-04051-2","volume":"39","author":"SH Chuang","year":"2025","unstructured":"Chuang, S. H. et al. Significance of serum biomarkers in preterm infants screened for retinopathy of prematurity: a systematic review and meta-analysis. Eye 39, 3167\u20133175 (2025).","journal-title":"Eye"},{"key":"5290_CR76","unstructured":"The Human Protein Atlas. VCAN [Internet]. Stockholm: The Human Protein Atlas; 2026 [updated 2026 Nov 11; cited 2026 April 20]. Available from: https:\/\/www.proteinatlas.org\/ENSG00000038427-VCAN."},{"key":"5290_CR77","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s42003-024-06007-w","volume":"7","author":"MD Li","year":"2024","unstructured":"Li, M. D. et al. ADAMTS4 is a crucial proteolytic enzyme for versican cleavage in the amnion at parturition. Commun. Biol. 7, 301 (2024).","journal-title":"Commun. Biol."},{"key":"5290_CR78","doi-asserted-by":"publisher","unstructured":"Nair, G. K. G. et al. Proteomic insight into the role of exosomes in proliferative vitreoretinopathy development. J. Clin. Med. 11, https:\/\/doi.org\/10.3390\/jcm11102716 (2022).","DOI":"10.3390\/jcm11102716"},{"key":"5290_CR79","doi-asserted-by":"publisher","unstructured":"Szeligowski, T. et al. Multimodal evaluation and management of Wagner syndrome-three patients from an affected family. Genes 15, https:\/\/doi.org\/10.3390\/genes15091178 (2024).","DOI":"10.3390\/genes15091178"},{"key":"5290_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03584-6","volume":"24","author":"Y Wen","year":"2024","unstructured":"Wen, Y. et al. Unmasking of molecular players: proteomic profiling of vitreous humor in pathologic myopia. BMC Ophthalmol. 24, 352 (2024).","journal-title":"BMC Ophthalmol."},{"key":"5290_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.24","volume":"1","author":"MK Gibson","year":"2016","unstructured":"Gibson, M. K. et al. Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome. Nat. Microbiol. 1, 16024 (2016).","journal-title":"Nat. Microbiol."},{"key":"5290_CR82","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jinf.2020.01.023","volume":"81","author":"P Zimmermann","year":"2020","unstructured":"Zimmermann, P. & Curtis, N. Breast milk microbiota: a review of the factors that influence composition. J. Infect. 81, 17\u201347 (2020).","journal-title":"J. Infect."},{"key":"5290_CR83","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.chom.2024.05.005","volume":"32","author":"M Selma-Royo","year":"2024","unstructured":"Selma-Royo, M. et al. Birthmode and environment-dependent microbiota transmission dynamics are complemented by breastfeeding during the first year. Cell Host Microbe 32, 996\u20131010.e1014 (2024).","journal-title":"Cell Host Microbe"},{"key":"5290_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61998-2","volume":"16","author":"S Rakoff-Nahoum","year":"2025","unstructured":"Rakoff-Nahoum, S. et al. A reconceptualized framework for human microbiome transmission in early life. Nat. Commun. 16, 7546 (2025).","journal-title":"Nat. Commun."},{"key":"5290_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2019.104854","volume":"138","author":"AC Masi","year":"2019","unstructured":"Masi, A. C. & Stewart, C. J. The role of the preterm intestinal microbiome in sepsis and necrotising enterocolitis. Early Hum. Dev. 138, 104854 (2019).","journal-title":"Early Hum. Dev."},{"key":"5290_CR86","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2523808","volume":"17","author":"DB Healy","year":"2025","unstructured":"Healy, D. B. et al. Late-onset sepsis treatment in very preterm infants alters longitudinal microbiome trajectory with lower abundance of Bifidobacterium despite probiotic supplementation. Gut Microbes 17, 2523808 (2025).","journal-title":"Gut Microbes"},{"key":"5290_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38156-7","volume":"14","author":"M Stocker","year":"2023","unstructured":"Stocker, M. et al. Less is more: antibiotics at the beginning of life. Nat. Commun. 14, 2423 (2023).","journal-title":"Nat. Commun."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05290-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05290-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05290-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:02:20Z","timestamp":1786478540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05290-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":88,"alternative-id":["5290"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05290-z","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent was obtained from parents or guardians before inclusion. The Mega Donna Mega study adhered to the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline.\n                      48\n                      The current nested cohort study has added a Strobe checklist for cohort studies.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Ethics"}}]}}